Details for Patent: 9,259,414
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which drugs does patent 9,259,414 protect, and when does it expire?
Patent 9,259,414 protects QBREXZA and is included in one NDA.
This patent has twenty-six patent family members in thirteen countries.
Summary for Patent: 9,259,414
| Title: | Glycopyrrolate salts |
| Abstract: | Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed. |
| Inventor(s): | Statler; John Allan (Redwood City, CA), Shaw; Anthony Adrian (North Vancouver, CA), Imbert; Delphine Caroline (Cupertino, CA), Nelson; Jennifer Leigh (Kokomo, IN), Andres; Patricia (West Lafayette, IN), McQueen; Lisa Lynn (West Lafayette, IN), Boerrigter; Stephan Xander Mattheus (West Lafayette, IN), Selbo; Jon Gordon (West Lafayette, IN), Andres; Mark Christopher (West Lafayette, IN) |
| Assignee: | Dermira, Inc. (Menlo Park, CA) |
| Application Number: | 14/643,553 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,259,414 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; |
Drugs Protected by US Patent 9,259,414
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Journey | QBREXZA | glycopyrronium tosylate | CLOTH;TOPICAL | 210361-001 | Jun 28, 2018 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | TOPICAL TREATMENT OF PRIMARY AXILLARY HYPERHIDROSIS IN ADULTS AND PEDIATRIC PATIENTS 9 YEARS OF AGE AND OLDER | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,259,414
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014223172 | See Plans and Pricing | |||
| Australia | 2016269524 | See Plans and Pricing | |||
| Canada | 2902795 | See Plans and Pricing | |||
| China | 105026369 | See Plans and Pricing | |||
| European Patent Office | 2961734 | See Plans and Pricing | |||
| European Patent Office | 3473615 | See Plans and Pricing | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
